IL7R and carcinoma: BTG2 (Shen et al., 2018), IL7R (Fan et al., 2021), and LAMP3 (Lindskog et al., 2014) are significantly downregulated in carcinoma samples, and their high expressions are markedly implicated with more prolonged overall survival, which is consistent with our study.